Light, laser, and stem cell therapy for melasma
Part of Skin clinical trials.
This trial combines light and laser treatments with stem cells from umbilical cord tissue to improve melasma (dark patches on the face). It may help reduce the patches and even out skin tone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 60 years old.
- You have melasma that has not changed for at least 3 months.
- You have not had stem cell or laser treatment for melasma before.
- You are not pregnant or breastfeeding.
- You have no history of severe reactions to sunlight or biological medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This trial tests a serum with ingredients like niacinamide to improve dark spots from acne and melasma, used alongside a laser treatment. It aims to see if the serum makes the laser more effective at lightening skin patches.
This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
Hear when a new Mesenchymal Stem Cells；Pigmentary Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.